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Abstract
The essential trace element zinc is important for all living organisms. Zinc functions not only as a nutritional factor, but also
as a second messenger. However, the effects of intracellular zinc on the B cell-receptor (BCR) signaling pathway remain
poorly understood. Here, we present data indicating that the increase in intracellular zinc level induced by ZIP9/SLC39A9 (a
ZIP Zrt-/Irt-like protein) plays an important role in the activation of Akt and Erk in response to BCR activation. In DT40 cells,
the enhancement of Akt and Erk phosphorylation following BCR activation requires intracellular zinc. To clarify this event,
we used chicken ZnT5/6/7-gene-triple-knockout DT40 (TKO) cells and chicken Zip9-knockout DT40 (cZip9KO) cells. The
levels of Akt and ERK phosphorylation significantly decreased in cZip9KO cells. In addition, the enzymatic activity of protein
tyrosine phosphatase (PTPase) increased in cZip9KO cells. These biochemical events were restored by overexpressing the
human Zip9 (hZip9) gene. Moreover, we found that the increase in intracellular zinc level depends on the expression of
ZIP9. This observation is in agreement with the increased levels of Akt and Erk phosphorylation and the inhibition of total
PTPase activity. We concluded that ZIP9 regulates cytosolic zinc level, resulting in the enhancement of Akt and Erk
phosphorylation. Our observations provide new mechanistic insights into the BCR signaling pathway underlying the
regulation of intracellular zinc level by ZIP9 in response to the BCR activation.
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Introduction
Zinc is an essential trace element for living organisms and is
contained in many proteins, such as zinc-finger-containing
transcriptional factors and zinc-dependent metalloenzymes [1].
Therefore, dysfunctions of zinc homeostasis are currently known
to be involved in the development of various diseases, such as
cancer, inflammation, and diabetes [2,3]. Two zinc transporter
families, namely, the Zinc transporter (ZnT)/solute carrier 30a
(Slc30a) family and the Zrt/Irt-like protein (ZIP)/solute carrier
39a (Slc39a) family, have been identified and characterized. There
are nine members of the ZnT family and 14 members of the ZIP
family, which tightly control cellular zinc homeostasis [4–6].
Recently, intracellular zinc has been established as a second
messenger molecule in breast cancer cells [7], lymphocytes [8–10],
and mast cells [11]. In cancer cells, ZIP7 induces the release of
zinc into the cytosol and the resulting increased intracellular zinc
level regulates the epidermal growth factor (EGF)/insulin-like
growth factor (IGF) signaling pathway [12]. Regarding this
signaling activation, it has been reported that ZIP7 is directly
phosphorylated by casein kinase (CK2) [13]. Phosphorylation of
ZIP7 leads to the release of zinc into the cytosol, leading to the
activation of signaling factors, such as Akt and Erk. In addition,
zinc has also been shown to affect the immune functions of the ZIP
and ZnT families, including the enhancements of T cell receptor
signaling and protein kinase C (PKC) signaling, and the regulation
of production of cytokines such as interleukin-2 (IL-2) and
interferon-gamma (INFgamma) [14,15]. The alteration of ZIP6
expression by lipopolysaccharides (LPS) in dendritic cells decreases
intracellular zinc level and induces dendritic maturation [16].
Moreover, the protein expression of ZIP8 is significantly induced
in infectious diseases and inflammation, and ZIP8-mediated zinc
transport into innate immune cells is important for proper immune
function [17,18]. Although many study have been reported that
the intracellular zinc regulates signaling pathway in T cell and
lymphocytes, however, the relationship of zinc and B cell receptor
(BCR) signaling has been poorly understood.
BCR signal transduction affects the expression of metabolic
genes or cytoskeletal proteins and leads to various cellular events
such as the survival, growth, and apoptosis of B cells [19–21]. To
clarify the molecular relationships among key signaling enzymes
such as PI3K, Ras, and PLCgamma in the BCR signaling, DT40
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chicken B cell lines have been utilized as a model [22–24].
Furthermore, the relationships between cellular zinc homeostasis
and zinc transporters have been characterized using DT 40
chicken B cells [25]. ZnT5, ZnT6, and ZnT7 (ZnT5/6/7), which
are located in the Golgi, incorporate intracellular zinc from the
cytosol into the Golgi. These transporters are required in the
loading of zinc to zinc-requiring enzymes, namely, alkaline
phosphatases, for enzyme activation and are indispensable in
homeostatic maintenance of secretory pathway function [26–29].
Furthermore, ZIP9 has also been identified and characterized as a
resident protein in the Golgi in DT40 and HeLa cell lines [30].
However, the function of ZIP9 is not understood well.
We hypothesized that zinc released to the cytosol as induced by
ZIP9 plays a pivotal role in the BCR signaling pathway. Thus, we
examined the mechanisms underlying the activation of BCR
signaling by intracellular zinc using cZip9KO cells established
from the DT40 chicken B lymphocyte cell line, which has been
used as a model to examine the significance of calcium in BCR
signaling [31,32]. First, by treating DT40 cells with an intracel-
lular zinc chelator, N,N,N9,N9-tetrakis(2-pyridylmethyl) ethylenedi-
amine (TPEN), we found that the levels of Akt and Erk
phosphorylation decreased under BCR activation by an anti-
IgM antibody. In addition, we observed that intracellular zinc
contributes to the increase in phosphorylation levels in DT40 cells
when intracellular zinc level was induced to increase using a zinc
ionophore, zinc pyrithione (ZnPy). Second, we found that the
phosphorylation of Akt and Erk triggered by the anti-IgM
antibody or ZnPy treatment was significantly attenuated in
cZip9KO cells. Under the same experimental conditions, the
enzymatic activity of protein tyrosine phosphatase (PTPase)
increased in cZip9KO cells. These biochemical events were
restored by overexpressing hZip9 in cZip9KO cells. Finally, by
fluorescence zinc staining, we detected that ZIP9 induced the
release of zinc into the cytosol from the Golgi. The altered
regulation of Akt and Erk in BCR signaling and PTPase activity in
cZip9KO cells indicate that intracellular zinc regulates BCR
signaling. Our observations provide new insights into the
mechanism of Akt and Erk activation in the BCR signaling
pathway, which underlies the regulation of intracellular zinc level
by ZIP9.
Materials and Methods
Materials
1-Hydroxypyridine-2-thione zinc salt and 2,29-dithiodipyridine
were obtained from Sigma-Aldrich, Inc. (Saint Louis, MO, USA).
N,N,N9,N9-Tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) was
obtained from Dojindo Molecular Technologies, Inc. (Kumamoto,
Japan). Ionomycin, calcium salt was obtained from Invitrogen
(Carlsbad, CA, USA). Newport Green PDX, FluoZin-3 and
BODIPY TR-ceramide were obtained from Molecular Probes
(Eugene, OR, USA). An anti-chicken IgM antibody (M4) was
purchased from Beckman Coulter, Inc. (Fullerton, CA, USA).
Specific antibodies against phospho-Ser473 Akt, Akt, phospho-
Thr202/Tyr204 p44/42 mitogen-activated protein kinase
(MAPK), and p44/42 MAPK, and hemagglutinin (HA)-Tag
(C29F4) were purchased from Cell Signaling Technologies
(Beverly, MA, USA). LY294002 as the PI3K inhibitor and
U0126 as the MEK1/2 inhibitor were also purchased from Cell
Signaling Technologies. Other chemical compounds were pur-
chased from Nacalai Tesque (Kyoto, Japan).
Cell culture, Treatment, Stimulation, and Protein Isolation
DT40 cell lines were cultivated in RPMI1640 supplemented
with 10% fetal bovine serum (FBS), 1% chicken serum (ChS), and
50 mM 2-mercaptoethanol (2ME) at 39.5uC in a humidified
atmosphere with 5% CO2. DNA was transfected into DT40 cells
as described previously to disrupt cZnT5/6/7 and cZip9 [26,27],
and hZip9-HA was reintroduced as describe previously [30].
Exponentially growing DT40 cells were starved in RPMI1640
supplemented with 0.5% BSA and 50 mM 2ME at 37uC for 5 h.
Cells were washed once with 0.5% BSA-HBSS (25 mM HEPES-
NaOH, pH 7.4, 120 mM NaCl, 0.8 mM MgCl2, 5.4 mM KCl,
and 2 mM CaCl2) and then resuspended in the same buffer at
3.56105 per 500 mL. The cells were stimulated with the anti-
chicken IgM antibody or treated with ZnPy, ZnCl2, or Py at 37uC
for 10 min or 30 min. In some experiments, the cells were
preincubated with LY294002 as the PI3K inhibitor or U0126 as
the MEK1/2 inhibitor at 37uC for 30 min before the treatment.
The cells were collected and washed once with 0.5% BSA-HBSS
and then lysed with a cell lysis buffer (50 mM Tris-HCl, pH 7.4,
150 mM NaCl, 1 mM EDTA, 1% Triton-X100, 0.1% SDS,
10 mM NaF, and 1 mM NaVO3) on ice for 15 min. Insoluble
materials were removed by centrifugation, and protein level was
measured by Bradford assay using BSA as the standard.
Western blot analysis
Whole-cell lysate (30 mg protein) was resolved on 10% SDS-
PAGE gels and separated proteins were transferred to nitrocellu-
lose membranes. The membranes were blocked with 5% (w/v)
nonfat skim milk in TBST (10 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 0.1% Tween 20) and immunoblotted with anti-phospho-
Ser473 Akt (pAkt), anti-Akt (Akt), anti-phospho-Thr202/Tyr204
p44/42 MAPK (pErk), anti-MAPK (Erk), or anti-HA (HA)
antibodies for overnight at 4uC in 5% BSA-TBST. After
incubation, the membranes were washed three times with TBST
and incubated for 1 h at room temperature with horseradish-
peroxidase-conjugated secondary antibodies. The immunoreactive
bands were visualized using Immobilon Western Chemilumines-
cent HRP substrates (Millipore, Billerica, MA, USA) and
membranes were scanned using the Chemi-Doc XRS system
(Bio-Rad, Hercules, CA, USA).
Measurement of PTPase activity
Cells were resuspended in 2 ml of cold homogenizing buffer
(0.25 M sucrose, 20 mM HEPES, and 1 mM EDTA) and
homogenized with 20 strokes of a Dounce homogenizer. To
remove the nucleus, the homogenate was centrifuged at 2,200 rpm
for 10 min at 4uC. The post-nuclear supernatant was centrifuged
at 12,000 rpm for 60 min at 4uC. The pellet containing
cytoplasmic and organelle membranes, was lysed in PTP lysis
buffer (50 mM Bis-Tris, 2 mM EDTA, pH 6.3 with HCl, 5 mM
DTT, 20% glycerol, and 0.1% Triton X-100). Insoluble materials
were removed by centrifugation (14,000 rpm for 5 min at 4uC),
and protein level was measured by Bradford assay using BSA as
the standard. 10 mg of lysate was preincubated at room
temperature for 10 min. After the preincubation, 100 mL of
substrate solution (10 mg/mL p-nitrophenyl phosphate in assay
buffer: 50 mM Bis-Tris, 2 mM EDTA, pH 6.3 with HCl, and
5 mM DTT) was added to the lysate, which was further incubated
at room temperature for 15 min. The level of p-nitrophenol
produced was measured at an absorbance of 405 nm. PTPase
activity was measured in terms of fold changes with respect to the
activity of untreated WT cells as the control.
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Zinc-specific fluorescence staining and measurement of
intracellular free zinc
Intracellular zinc staining was performed as described previ-
ously [29]. DT40 cells at 70% confluence were starved in
RPMI1640 supplemented with 0.5% BSA and 50 mM 2ME at
37uC for 5 h. The cells were treated with 5 mM Newport Green
PDX or FluoZin-3 for 30 min on coverslips coated with 0.05%
poly-L lysine before treating them with ZnPy or the anti-IgM (M4)
antibody for 10 min. To stain the Golgi, we used BODIPY TR
ceramide (red fluorescence), and performed staining with Newport
Green PDX or FluoZin-3. The cells were visualized by confocal
fluorescence microscopy (Carl Zeiss LSM510, Germany). In
addition, 56105 DT40 cells were subjected to the experiment of
intracellular zinc measurement using Newport Green PDX. The
concentration of intracellular free zinc was calculated from the
mean fluorescence with the formula [Zn] =KD6[(F2Fmin)/
(Fmax2F)]. Fmin was determined by the addition of 10 mM TPEN,
and Fmax was determined by the addition of 75 mM ZnPy [33,34].
For a calibration of these zinc measurements, we evaluated the
amount of Newport Green PDX integrated into cells [33]. After
treatment of Newport Green PDX (5 mM for 30 min), washed out
with 0.5% BSA/HBSS, and then lysed with HBSS buffer
containing 50 mM digitonin, and added excessive amounts of
ZnSO4 (20 mM). The concentration of Newport Green PDX in
DT40 cells was calculated using the calibration curve. Values are
expressed as the mean 6 standard deviations. Experiments and
measurements were performed in triplicate independently.
Statistical analyses
For multiple comparisons, one-way analysis of variance was
performed followed by Bonferroni’s Multiple Comparison Test
using GraphPad Prism 5 software. Differences were considered
significant at P,0.01.
Results
Activation of Akt and Erk phosphorylation by BCR
activation requires intracellular zinc
We first examined the impact of intracellular zinc level on the
antigen-stimulated BCR signaling pathway. Western blot analysis
was performed using lysates prepared from cells treated with or
without the intracellular zinc chelator TPEN, using specific
antibodies to total or phosphoforms of Akt and Erk (Figure 1A).
We observed that the activation of BCR by the anti-IgM antibody
induced the phosphorylation of Akt and Erk (Figure 1A, lane 2).
Surprisingly, we found that the phosphorylation of Akt and Erk
was not complete following the stimulation with the anti-IgM
antibody when the cells were pretreated with 10 mM TPEN for
1 h (Figure 1A, lane 3). These suppressions were restored by the
addition of 10–20 mM zinc pyrithione (ZnPy), but not recovered
by calcium salt of ionomycin (CaI) (Figure 1A, lanes 4, 5 and 6).
To assess whether zinc is involved in the phosphorylation of Akt
and Erk, DT40 cells were treated with zinc chloride (ZnCl2) and
ZnPy at different concentrations and with the anti-IgM antibody.
Figure 1B shows that the phosphorylation levels of Akt and Erk
were significantly increased by 5–10 mM ZnPy as well as by the
anti-IgM antibody (Figure 1B, lanes 2, 5, and 6). On the other
hand, ZnCl2 and pyrithione (Py), which does not contain zinc, did
not induce the phosphorylation of both proteins (Figure 1B, lanes
3, 4, and 7). We also determined whether ZnPy induces the
phosphorylation of Akt and Erk in a dose-dependent manner.
ZnPy enhanced the phosphorylation of both Akt and Erk in a
dose-dependent manner, and Erk phosphorylation level was
decreased by 25 mM ZnPy treatment (data not shown).
We next examined the time-dependence of the phosphorylation
of Akt and Erk induced by ZnPy. The cells were treated with
10 mM ZnPy for the indicated durations to determine the optimal
treatment time (Figure 1C). Akt phosphorylation by ZnPy was
most enhanced by treatment for 10–15 min, but the enhancement
was diminished at 60 min of treatment (Figure 1C, first panel;
lanes 2–6). In contrast, Erk phosphorylation by ZnPy remained
until 60 min. (Figure 1C, third panel; lanes 2–6).
To further investigate the phosphorylation of Akt and Erk by
ZnPy treatment in DT40 cells, the cells were pretreated with
LY294002 (PI3K inhibitor) or U0126 (MEK1/2 inhibitor) before
treatment with the anti-IgM antibody and ZnPy. Figure 1D shows
that the phosphorylation levels of Akt and Erk decreased in the
presence of their respective inhibitors (Figure 1D, lanes 3 and 7
indicate LY294002, and lanes 4 and 8 indicate U0126).
Thus, the enhancement of Akt and Erk phosphorylation
requires intracellular zinc and ZnPy, a zinc ionophore, which
can solely activate the BCR signaling pathway.
The phosphorylation of Akt and Erk is suppressed in the
chicken Zip9-knockout DT40 cells
We examined whether the fluctuations of the levels of Akt and
Erk phosphorylation are caused by the changes in intracellular
zinc level, which was regulated by the zinc transporters. To study
this mechanism, we used the two zinc-transporter-knockout cells,
chicken ZnT5/6/7 triple knockout (TKO) DT40 cells, and
chicken Zip9 gene knockout (cZip9KO) DT40 cells [26–30].
We first examined the levels of Akt and Erk phosphorylation in
these exponentially growing knockout DT40 cells in the presence
of serum. The levels of Akt and Erk phosphorylation were identical
in WT and TKO cells (Figure 2A, lanes 1 and 2). In contrast,
surprisingly, the levels of Akt and Erk phosphorylation of
cZip9KO cells significantly decreased (Figure 2A, lane 3). Under
the same experimental conditions, we analyzed the activity of total
protein tyrosine phosphatase (PTPase) using p-nitrophenol as a
substrate. Figure 2B shows that the activity of PTPase decreased in
TKO cells (gray column) as compared with that in wild-type (WT)
cells (hatched column). On the other hand, the activity in
cZip9KO cells moderately increased (white column).
To further investigate the phosphorylation levels of both
proteins in TKO and cZip9KO cells, we examined whether ZnPy
enhances the phosphorylation of Akt and Erk under serum-starved
conditions. Figure 2C shows that the phosphorylation levels of Akt
and Erk in WT and TKO cells were increased by the treatment
with ZnPy (lanes 2 and 4). In TKO cells, the level of Erk
phosphorylation did not decrease even under the serum-starved
conditions (Figure 2C, third panel; lane 3). On the other hand,
ZnPy did not increase the phosphorylation levels of Akt and Erk in
cZip9KO cells (Figure 2C, lane 6). To confirm this observation,
we also analyzed the activity of PTPase under the same
experimental conditions. Figure 2D shows that the activity of
total PTPase was decreased by the treatment with ZnPy in WT
cells (hatched column 2). Total PTPase activity in ZnPy-treated
TKO cells did not decrease significantly compared with that in
non-ZnPy-treated TKO cells (gray columns 3 and 4). The activity
of PTPase in non-ZnPy-treated TKO cells was slightly lower than
that in WT cells (hatched column 1 and gray column 3). In
contrast, the total PTPase activity in cZip9KO cells markedly
increased (Figure 2C, white columns 5 and 6). These findings
suggest that the regulation of intracellular zinc level by cZip9 in
DT40 cells is required to increase the phosphorylation levels of Akt
and Erk, at least in part, by inhibiting PTPase activity.
ZIP9 Regulates the Activations of BCR Signaling
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Overexpression of human ZIP9 in cZip9KO cells restores
the enhancement of Akt and Erk phosphorylation in
response to zinc treatment and antigen-stimulated BCR
We demonstrated that cZip9 in DT40 cells function in the
regulation of Akt and Erk phosphorylation. To clarify the effects of
ZIP9 on both kinases, we overexpressed human Zip9 tagged with
the hemagglutinin epitope (hZip9-HA) in cZip9KO cells and used
the cells in the following experiments.
We re-estimated the phosphorylation levels of Akt and Erk by
overexpressing hZip9-HA in exponentially growing cZip9KO cells
in the presence of serum. As shown in Figure 3A, the
overexpression of hZip9-HA in cZip9KO cells restored the
phosphorylation of both proteins (Figure 3A, lane 3). In addition,
the total PTPase activity in these cells was similar to that in WT
cells under the same experimental conditions (data not shown).
Under the serum-starved conditions, where we more closely
examined the effects of ZnPy with time, we found that the
phosphorylation of Akt was not enhanced in cZip9KO cells with
ZnPy treatment for 10 and 30 min (Figure 3B, first panel; lanes 5
and 6) compared with that in WT cells (Figure 3B, first panel;
lanes 2 and 3). Although the phosphorylation of Erk in cZip9KO
cells was not enhanced after 10 min of ZnPy treatment, the
phosphoform of Erk was detected following treatment with ZnPy
for 30 min (Figure 3A, third panel; lanes 5 and 6). In contrast,
hZip9-HA-overexpressing cZip9KO cells showed higher levels of
the phosphoforms of both proteins than non-hZip9-HA-overex-
pressing cZip9KO cells (Figure 3B, lanes 8 and 9). ZnPy did not
alter the protein level of hZip9-HA (Figure 3B, fifth panel; lanes 7–
9). Under the same experimental conditions, we observed that the
treatment with ZnPy inhibited the activity of total PTPase in the
hZip9-HA-overexpressing cZip9KO cells compared with the non-
hZip9-HA-overexpressing cZip9KO cells (Figure 3C, columns 5
and 8).
Figure 1A shows that the intracellular zinc chelation inhibits the
phosphorylation of Akt and Erk in response BCR activation. Thus,
we examined the effects of ZIP9 in response to anti-IgM antibody-
stimulated BCR. Figure 3D shows that the phosphorylation levels
of Akt and Erk did not increase in cZip9KO cells following the
anti-IgM antibody treatment, in comparison with those in WT
cells (Figure 3D, lanes 1–4). In contrast, the inhibitory effect on the
phosphoforms of both kinases in cZip9KO cells was reversed by
the overexpression of hZip9-HA (Figure 3D, first and third panels;
lanes 4 and 6). The protein level of hZip9-HA was constant
(Figure 3D, fifth panel; lanes 5 and 6).
Our experimental data indicate that ZIP9 plays an important
role in the enhancement of Akt and Erk phosphorylation in
response to the treatment with ZnPy and the anti-IgM antibody-
activated BCR. In addition, the activation by the anti-IgM
antibody significantly decreased the levels of phosphoforms of both
proteins in cZip9KO cells. These observations coincide with the
attenuation of Akt and Erk phosphorylation in TPEN-treated WT
cells (Figure 1A).
Figure 1. Effect of intracellular zinc on enhancement of Akt and Erk phosphorylation. (A) Enhancement of Akt and Erk phosphorylation
required intracellular zinc. Serum-starved cells were treated with (+) or without (2) 10 mM TPEN for 1 h, before treatment with 0.5 mg/mL anti-IgM
antibody (lane 2 and 3), and then treated with 10 and 20 mM ZnPy (lane 4 and 5) or 10 mM CaI (lane 6). (B) The treatment with ZnPy activated the
phosphorylation of Akt and Erk. The abbreviation, ‘‘unt.’’ was defined the untreated sample. Serum-starved cells were treated with 0.5 mg/mL anti-
IgM antibody (lane 2), 5 and 10 mM ZnCl2 (lanes 3 and 4), 5 and 10 mM ZnPy (lanes 5 and 6), and 20 mM pyrithione (lane 7) for 10 min. (C) Akt and Erk
phosphorylation by ZnPy was enhanced in a time-dependent manner. The abbreviation, ‘‘unt.’’ was defined the untreated sample. Serum-starved
cells were treated with 10 mM ZnPy for 5 min (lane 2), 10 min (lane 3), 15 min (lane 4), 30 min (lane 5), and 60 min (lane 6). (D) The inhibitors of PI3K
and MEK1/2 inhibited the phosphorylation of Akt and Erk. Serum-starved cells were pretreated with (+) or without (2) LY294002 or U0126, before
treatments with 0.5 mg/mL anti-IgM antibody (lanes 1–4) and 10 mM ZnPy (lanes 5–8). All data are representative of three independent experiments.
doi:10.1371/journal.pone.0058022.g001
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ZIP9 increases intracellular zinc level in response to BCR
activation
A previous study demonstrated the presence of intracellular zinc
around perinuclear regions and zincosome-like vesicles in
cZip9KO cells using the zinc fluorescent probe zinquin [30]. It
has been reported that zinquin recognizes mainly the zinc in
subcellular compartments [35]. Hence, we performed the detec-
tion of intracellular zinc with confocal fluorescence microscope by
using two types of zinc-specific fluorescent probes, Newport Green
PDX (KD=30 mM) and FluoZin-3 (KD= 15 nM) that have
different distribution in the cells. As shown in Figure 4A, the
fluorescence intensity of Newport Green PDX in WT cells treated
with ZnPy was higher than that in untreated WT cells (Figure 4A,
panels a and b). In contrast, we observed that the level of cytosolic
zinc was not increased in cZip9KO cells by the ZnPy treatments
(Figure 4A, panels c and d). On the other hand, the overexpression
of hZIP9-HA restored the intracellular zinc contents in cZip9KO
cells as well as WT cells, when the cells were treated with ZnPy
(Figure 4A, panels e and f). In the staining with FluoZin-3,
fluorescence intensity was increased by ZnPy treatment in WT
and hZip9-HA-overexpressing cZip9KO cells as well as in
Newport Green PDX staining. However, FluoZin-3 fluorescence
of cZip9KO cells was localized at the Golgi, even if it was treated
with ZnPy (Figure 4A, panels i and j).
When DT40 cells were treated with anti-IgM antibody,
cytosolic zinc was also increased in WT cells (Figure 4B, panels
a and d: Untreated WT cells = 2.0560.17 mM and anti-IgM
antibody stimulated WT cells = 2.8760.30 mM). Whereas, intra-
cellular zinc level in cZip9KO cells was lower than that in WT
cells even if it was stimulated with anti-IgM antibody (Figure 4B,
panels b and e: Untreated cZip9KO cells = 0.5860.09 mM and
anti-IgM antibody stimulated cZip9KO cells = 0.8760.13 mM). In
addition, hZip9-HA-overexpressing cZip9KO cells restore this
decrease of cytosolic zinc, as well as treatment with ZnPy
(Figure 4B, panels c and f: Untreated hZip9-HA-overexpressing
cZip9KO cells = 1.8860.18 mM and anti-IgM antibody stimulat-
ed hZip9-HA-overexpressing cZip9KO cells = 2.7160.14 mM).
We also observed that anti-IgM antibody stimulation for 5 min
induced increase of intracellular zinc level in 56105 DT40 cells
(Untreated cells = 2.0560.17 mM, DT40 cells stimulated with
anti-IgM antibody for 5 min= 2.6160.22 mM, and stimulated for
10 min= 2.8760.30 mM). These results suggested that intracellu-
lar zinc elevation by anti-IgM antibody appear prior to Akt and
Erk phosphorylation, and there are sufficient amount of intracel-
lular zinc for the activation of Akt and Erk after 5 min anti-IgM
antibody stimuli. In addition, we demonstrated that more than
96.6% of Newport Green PDX had been incorporated in 56105
DT40 cells (WTcells = 4.8960.80 mM, cZip9KO
Figure 2. Akt and Erk phosphorylation in zinc-transporter-knockout DT40 cells. (A) Suppression of Akt and Erk phosphorylation in cZip9KO
cells. Western blot analysis was performed using exponentially growing WT (lane 1), TKO (lane 2), and cZip9KO (lane 3) cells. (B) Analysis of total
PTPase activity. WT (column 1), TKO (column 2), and cZip9KO (column 3) cells were subjected to PTPase assay. Values are expressed as the mean 6
standard deviations. Significant difference at the level of *P,0.01 against the activity of WT cells (column 1). (C) ZnPy failed to induce Akt and Erk
phosphorylation in cZip9KO cells. Serum-starved WT (lanes 1 and 2), TKO (lanes 3 and 4), and cZip9KO (lanes 5 and 6) cells were treated with (+) or
without (2) 10 mM ZnPy for 10 min. (D) Analysis of PTPase activity in serum-starved DT40 cells. After treatment of serum-starved WT (columns 1 and
2), TKO (columns 3 and 4), and cZip9KO (columns 4 and 5) cells treated with (columns 2, 4 and 6) or without (columns 1, 3 and 5) 10 mM ZnPy for
10 min, and subjected to PTPase assay. Values are expressed as the mean6 standard deviations. Asterisk represents significant difference at the level
of *P,0.01 for the columns linked by a line. All data are representative of three independent experiments.
doi:10.1371/journal.pone.0058022.g002
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cells = 4.8360.43 mM, and hZip9-HA-overexpressing cZip9KO
cells = 4.9060.46 mM).
Considering that ZIP9 is the Golgi-resident protein, these
findings suggest that the increase in cytosolic zinc level is caused by
zinc release from an intracellular store induced by ZIP9 through
BCR activation. This observation is in agreement with the levels of
Akt and Erk phosphorylation and the inhibition of total PTPase
activity (Figure 3).
Discussion
The essential trace element zinc is an important metal for all
living organisms. Zinc is not only a nutrition factor, but it also
functions as a second messenger [11]. Zinc homeostasis is tightly
mainly regulated by two-types of zinc transporters, such as those
belonging to the ZnT family and ZIP family. The latter zinc
transporter family consists of 14 transporter proteins that are
classified into four subfamilies (I, II, LIV-1, and gufA). Although
the roles of ZIP family proteins have been extensively investigated
and thus their importance has been elucidated [13,17,36],
information available has been limited to that on the LIV-I and
ZIP II subfamilies [25]. The cellular functions of ZIP9 belonging
to the subfamily I have not been fully understood.
Intracellular zinc affects the immune functions of T-cells and
lymphocytes including the activation of TCR signaling and
cytokine production [8]. It has been reported that the increase
in intracellular zinc level not only induces the activation of LCK
and PKC [37], but also enhances the tyrosine phosphorylation of
ZAP70, leading to the activation of the TCR signaling pathway
[10]. The BCR signaling pathway is critical for many cellular
events, such as cell growth, cell proliferation, and apoptosis [22–
24]. BCR activation transduces the signal to several cascades, such
as the PI3K-Akt, PLCgamma 2-PKC, and Ras-Raf-Erk cascades
[24,38,39]. These cascades are important for the differentiation to
antibody-producing cells and memory B cells. However, the effect
of the intracellular zinc on the BCR signaling pathway remains
unclear.
In this study, we examined the effect of intracellular zinc on the
BCR signaling pathway activated by ZIP9 using the DT40 chicken
B lymphocyte cell line as a model. Treating the cells with TPEN
Figure 3. Effect of overexpression of human Zip9 on phosphorylation levels of Akt and Erk in response to zinc treatment and anti-
IgM antibody stimulation. (A) Overexpression of hZip9 restored the phosphorylation of Akt and Erk. Western blot analysis was performed using
exponentially growing WT (lane 1), cZip9KO (lane 2), and cZip9KO+hZip9HA (lane 3) cells. (B) Overexpression of hZip9 in cZip9KO cells by ZyPy
treatment stimulated the phosphorylation of both proteins. Serum-starved WT (lanes 1–3), cZip9KO (lanes 4–6), and cZip9KO+hZip9HA (lanes 7–9)
cells were treated with 10 mM ZnPy for 10 min (lanes 2, 5 and 8) and 30 min (lanes 3, 6 and 9). The abbreviation, ‘‘unt.’’ was defined the untreated
sample. (C) Analysis of total PTPase activity. Serum-starved WT (lanes 1–3), cZip9KO (lanes 4–6), and cZip9KO+hZip9HA (lanes 7–9) cells were treated
with 10 mM ZnPy for 10 min (lanes 2, 5 and 8) and 30 min (lanes 3, 6 and 9). Values are expressed as the mean 6 standard deviations. Significant
difference at the level of *P,0.01 for the columns linked by a line. (D) Overexpression of hZip9 restored the response to anti-IgM antibody-stimulated
BCR activation. Serum-starved WT (lanes 1 and 2), cZip9KO (lanes 3 and 4), and hZip9-HA-overexpressing cZip9KO (lanes 5 and 6) cells were treated
with 0.5 mg/mL anti-IgM antibody for 10 min. All data are representative of three independent experiments.
doi:10.1371/journal.pone.0058022.g003
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suppressed the Akt and Erk phosphorylation enhanced by BCR
activation by the anti-IgM antibody. This suppression was
reversed by supplementation of exogenous zinc into the cells
(Figure 1A, lanes 4 and 5). In addition, the treatment of ZnPy
without the anti-IgM antibody induced Akt and Erk phosphory-
lation in time- and concentration-dependent manners. Further-
more, the phosphorylation of both proteins was inhibited by the
specific inhibitors of PI3K and MEK1/2. These observations
indicate that intracellular zinc is necessary for the activation of the
BCR signaling pathway. However, it has not been clarified
whether zinc transporters are involved in the regulation of this
signaling pathway.
ZIP9 has been suggested to function in the release of zinc from
the Golgi to the cytosol. We investigated direct correlation
between the effect of ZIP9 and the BCR signaling pathway.
Interestingly, the phosphorylation of both Akt and Erk was
suppressed by the disruption of cZip9 in exponentially growing
DT40 cells. This suppression was also observed in the serum-
starved cells, even if they were treated with ZnPy or the anti-IgM
antibody (Figures 2 and 3).
In TKO cells, the phosphorylation levels of Akt and Erk were
similar to those in WT cells under the exponential growth
condition (Figure 2A, lane 2). This finding raises the possibility
that the accumulation of zinc in the Golgi is due to a ZnT5/6/7-
independent mechanism. In contrast, the increase in the levels of
these phosphoforms of proteins may be the result of inhibition of
PTPase by cytosolic zinc, which is not incorporated into the Golgi.
Further testing of these hypotheses is needed to clarify whether
zinc transport into Golgi via ZnT5/6/7 is required for the function
of ZIP9. In addition, the level of Erk phosphorylation did not
decrease, even under the serum-starved condition. This finding
seems to support the idea of sustained inhibition of PTPase by
cytosolic zinc against the Erk cascade. The phosphorylation levels
of Akt and Erk increased in the TKO cells as well as in WT cells
under the ZnPy treatment conditions (Figure 2C). This finding
suggests that ZnPy is incorporated in the Golgi [29] and then
release from the Golgi via ZIP9, indicating that zinc trafficking
mediated by cZIP9 is involved in the activation of the BCR
signaling pathway.
Furthermore, we explored whether this activation is dependent
on ZIP9, of which sequence is 89% identical to the cZIP9 protein
[30]. Therefore, hZIP9-HA was overexpressed in cZip9KO cells
to determine the effects of ZIP9. We observed that hZIP9-HA
overexpression restored the enhancement of Akt and Erk
phosphorylation in cells treated with ZnPy and the BCR signaling
pathway treated with the anti-IgM antibody (Figures 3B and 3D).
We further explored whether the phosphorylation of Akt and
Erk is regulated by PTPase. Our findings indicate that PTPase
activity was significantly higher in cZip9KO cells than in WT cells
(Figures 2D and 3C). In contrast, PTPase activity was decreased
by overexpression of hZip9-HA in ZnPy-treated cZip9KO cells
(Figure 3C). cZip9KO cells retained high activity of PTPase, even
if cells were treated with ZnPy (Figure 3C, white columns 4, 5 and
6). These data indicate ZIP9 may inhibit PTPase activity.
We speculate two alternative explanations for the mechanism of
PTPase inhibition by ZIP9. First, ZIP9 might elevate local zinc
concentration on the Golgi where PTPase is in close proximity to
ZIP9. Hence, liberated zinc from Golgi by ZIP9 could bind to the
cysteine residue in the active site of PTPase and subsequently
reduce its activity [40,41]. Second, the released zinc could
modulate protein stability. It has been reported that zinc inhibits
PTEN activity in human airway epithelial cells [42] by zinc-
induced its ubiquitin-dependent degradation [43]. As such, free
zinc generated by ZIP9 could be involved in the proteolysis of
PTPase through the ubiquitin-proteasome system.
Our findings suggest that the activation of the BCR signaling
pathway following the treatment with ZnPy and the anti-IgM
antibody is indeed the function of ZIP9. However, a question
remains whether BCR activation increases the zinc influx through
ZIP9 into the cytosol. It has been reported that the intracellular
zinc level is altered by changes in the protein expression level of
the zinc transporter [44] and the release of zinc from the ER in
response to extracellular stimulation [11,13]. We observed a
significant fluorescence intensity of intracellular zinc in both
Figure 4. ZIP9 is an essential factor for regulating the intracellular zinc level in DT40 cells. (A) The intracellular zinc release depends on
the expression of ZIP9. Serum-starved WT (panels a, b, g and h), cZip9KO (panels c, d, i and j), and hZip9-HA-overexpressing cZip9KO (panels e, f, k
and l) DT40 cells were pretreated with 5 mM Newport Green PDX (magnification;640), FluoZin-3 (magnification;660) and BODIPY TR-ceramide for
30 min before treatment with 10 mM ZnPy (WT: panels b and h, cZip9KO: panels d and j, hZip9-HA-overexpressing cZip9KO: panels f and l) for 10 min.
(B) Serum-starved WT (panels a and d), cZip9KO (panels b and e), and hZip9-HA-overexpressing cZip9KO (panels c and f) DT40 cells were pretreated
with 5 mM Newport Green PDX (magnification;640) and BODIPY TR-ceramide for 30 min before treatment with 0.5 mg/mL anti-IgM antibody (WT:
panel d, cZip9KO: panel e, hZip9-HA-overexpressing cZip9KO: panel f) for 10 min. The abbreviation, ‘‘unt.’’ was defined the untreated sample, and
white bars were defined as 10 mm length.
doi:10.1371/journal.pone.0058022.g004
Figure 5. Proposed action sites of intracellular zinc release by
ZIP9 in DT40 cells for activation of B cell receptor signaling. It is
the proposed mechanism of Zn-induced PTPase inhibition by ZIP9,
which leads to the activation of B cell receptor signaling in DT40 cells.
Intracellular zinc is incorporated into the Golgi by ZnT5/6/7. Zinc is
released as induced by ZIP9 into the cytosol from the Golgi, which in
turn inhibits PTPase activity and induces the phosphorylation of Akt
and ERK probably indirectly by regulating upstream components of the
signal transduction.
doi:10.1371/journal.pone.0058022.g005
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exponentially growing WT and hZip9-HA-overexpressing
cZip9KO cells (data not shown). In addition, we revealed the
intracellular zinc distribution in DT40 cells that were serum-
starved and treated with ZnPy or the anti-IgM antibody by using
Newport Green PDX and FluoZin-3. These results showed that
zinc is accumulated and retained into the Golgi in cZip9KO cells
(Figure 4). We analyzed that Zip9 mRNA was ubiquitously
expressed in the mouse tissues and several cell lines, such as HeLa,
MCF7, and NIH3T3 cells (data not shown). One of them, we
confirmed that treatment of ZnPy increased florescence intensity
of zinc in the Golgi of Zip9 siRNA-treated HeLa cells
(unpublished data). This supporting observation might indicate
that ZIP9 release zinc from the Golgi to the cytosol in mammalian
cells as well as DT40 cells.
It is known that zinc waves occur together with calcium waves
[11,13]. Antigen-stimulated BCR has been shown to trigger
calcium release via the inositol 1,4,5-triphosphate receptor (IP3R)
from the ER and also to incorporate extracellular calcium via the
calcium-release-activated calcium channel (CRAC/ORAI) that is
coupled with the stromal interaction molecule (STIM) in DT40
cells [31,45,46]. From this point of view, the function of ZIP9 may
require intracellular calcium. The relationship between calcium
and the ZIP9 function remains unclear. However, importantly,
our data suggest that the increase in intracellular zinc level
through ZIP9 is regulated by BCR activation without exogenous
zinc, and coincides with the enhancement of Akt and Erk
phosphorylation.
It has been reported that ZIP7 and ZIP13 that are located in the
ER, the Golgi, or both increase the zinc influx into the cytosol in
response to EGF/IGF and TGFß/BMP stimulations, respectively
[12,36,47–49]. The function of ZIP7 has been also reported to be
necessary to phosphorylate ZIP7 by CK2 in the human breast
cancer cell line [13]. On the other hand, the regulation of zinc
influx through ZIP13 by TGFß/BMP operates in the nuclear/
cytosol shuttle of Smad2/3, which supply zinc into the mad-
homology domain on Smad2/3 in primary dermal fibroblasts of
mice [49]. More recently, a homodimer complex of ZIP13 is
fundamental to the zinc influx [50]. Our findings reveal that the
zinc release function of ZIP9 seems to be similar to that of ZIP7
and ZIP13. However, ZIP7 and ZIP13 are members of the LIV-1
subfamily and these two transporters are similar. Moreover, ZIP9
may have retained important function in chicken cells because the
ZIP7 protein is not expressed in chicken [25]. Thus, the functional
mechanism in mammalian or human cells, which is post-
translational modification, or the higher-order structure of ZIP9
needs to be elucidated in further investigation.
Our findings indicate that the function of ZIP9 affects the level
of cytosolic zinc, resulting in the activation of signaling kinase via
PTPase inhibition in DT40 cells (Figure 5). As we have shown in
this study, this is the first evidence for the function of the subfamily
I of the ZIP family that could explain the relationship between the
increase of intracellular zinc level by ZIP9 and BCR activation.
These observations provide new mechanistic insights into signaling
molecules and B-cell fate underlying the regulation of intracellular
zinc level by ZIP9 in the response to antigen-stimulated BCR.
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